Myriad Genetics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Myriad Genetics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 191.90M	$ 183.50M	$ 181.20M	$ 177.80M	$ 156.40M
Gross Profit	$ 134.30M	$ 125.70M	$ 122.00M	$ 123.90M	$ 106.00M
EBIT	$ -60.20M	$ -115.60M	$ -52.10M	$ -52.20M	$ -43.40M
EBITDA	$ -43.30M	$ -99.40M	$ -29.80M	$ -35.40M	$ -30.30M
Net Income Common Stockholders	$ -61.30M	$ -116.10M	$ -54.70M	$ -42.30M	$ -35.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 86.30M	$ 121.60M	$ 78.70M	$ 114.90M	$ 193.20M
Total Assets	$ 1.15B	$ 1.19B	$ 1.17B	$ 1.20B	$ 1.21B
Total Debt	$ 201.40M	$ 203.80M	$ 161.60M	$ 145.00M	$ 137.30M
Net Debt	$ 115.10M	$ 82.20M	$ 82.90M	$ 30.10M	$ -55.90M
Total Liabilities	$ 465.70M	$ 452.00M	$ 334.10M	$ 1.20B	$ 295.40M
Stockholders Equity	$ 683.40M	$ 735.20M	$ 835.20M	$ 885.80M	$ 916.60M
Cash Flow	-
Free Cash Flow	$ -33.00M	$ -36.00M	$ -56.70M	$ -31.70M	$ -19.50M
Operating Cash Flow	$ -22.10M	$ -17.20M	$ -33.20M	$ -17.10M	$ -1.80M
Investing Cash Flow	$ -2.50M	$ 28.10M	$ 34.60M	$ -26.20M	$ 11.40M
Financing Cash Flow	$ -2.50M	$ 38.40M	$ -4.90M	$ -2.10M	$ -3.60M

Currency in USD

Myriad Genetics Earnings and Revenue History

Income Statement >

Myriad Genetics Debt to Assets

Balance Sheet >

Myriad Genetics Cash Flow

Cash Flow >

Myriad Genetics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing